{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:03:18Z","timestamp":1784106198143,"version":"3.55.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222868","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T13:29:27Z","timestamp":1569245367000},"page":"e0222868","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4700-2823","authenticated-orcid":true,"given":"Tiffany E.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleetwood","family":"Loustalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"issue":"10","key":"pone.0222868.ref001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association","volume":"139","author":"EJ Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"pone.0222868.ref002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"PA Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"pone.0222868.ref003","unstructured":"Agency for Healthcare Research and Quality. Guide to Prevention Quality Indicators: Hospital Admission for Ambulatory Care Sensitive Conditions Available: http:\/\/www.qualityindicators.ahrq.gov\/Downloads\/Modules\/PQI\/V31\/pqi_guide_v31.pdf. Accessed April 26, 2018."},{"key":"pone.0222868.ref004","first-page":"E85","article-title":"Preventable hospitalizations for congestive heart failure: establishing a baseline to monitor trends and disparities","volume":"9","author":"JC Will","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"pone.0222868.ref005","unstructured":"Readmissions Reduction Program (HRRP). Available: https:\/\/www.cms.gov\/medicare\/medicare-fee-for-service-payment\/acuteinpatientpps\/readmissions-reduction-program.html. Accessed October 26, 2018."},{"key":"pone.0222868.ref006","unstructured":"Hospital to Home. Available: https:\/\/cvquality.acc.org\/initiatives\/hospital-to-home. Accessed October 26, 2018."},{"issue":"16","key":"pone.0222868.ref007","first-page":"e147","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"CW Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"pone.0222868.ref008","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes","volume":"70","author":"KS Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pone.0222868.ref009","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/phar.2107","article-title":"Association Between Medication Adherence and the Outcomes of Heart Failure","volume":"38","author":"SR Hood","year":"2018","journal-title":"Pharmacotherapy"},{"key":"pone.0222868.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PPA.S54520","article-title":"Electronically monitored medication adherence predicts hospitalization in heart failure patients","volume":"8","author":"B Riegel","year":"2013","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"pone.0222868.ref011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002606","article-title":"Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials","volume":"5","author":"TM Ruppar","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"pone.0222868.ref012","first-page":"556","article-title":"Medication adherence and Medicare expenditure among beneficiaries with heart failure","volume":"18","author":"R Lopert","year":"2012","journal-title":"Am J Manag Care"},{"issue":"3","key":"pone.0222868.ref013","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MLR.0000000000001067","article-title":"How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?","volume":"57","author":"JT Lloyd","year":"2019","journal-title":"Med Care"},{"issue":"8","key":"pone.0222868.ref014","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cardfail.2011.04.011","article-title":"Impact of medication nonadherence on hospitalizations and mortality in heart failure","volume":"17","author":"AA Fitzgerald","year":"2011","journal-title":"J Card Fail"},{"issue":"3","key":"pone.0222868.ref015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjcard.2015.04.058","article-title":"Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study)","volume":"116","author":"CA Sueta","year":"2015","journal-title":"Am J Cardiol"},{"issue":"4","key":"pone.0222868.ref016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11606-013-2692-x","article-title":"Race\/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure","volume":"29","author":"Y Zhang","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"8","key":"pone.0222868.ref017","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.clinthera.2007.08.015","article-title":"Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure","volume":"29","author":"AD Bagchi","year":"2007","journal-title":"Clin Ther"},{"key":"pone.0222868.ref018","unstructured":"Hansen L, Chang S. White paper: Health research data for the real world: the MarketScan Databases 2011. Available: http:\/\/truvenhealth.com\/portals\/0\/assets\/PH_11238_0612_TEMP_MarketScan_WP_FINAL.pdf. Accessed June 29, 2018."},{"key":"pone.0222868.ref019","unstructured":"Agency for Healthcare Research and Quality. Prevention quality indicators technical specifications. Available: http:\/\/www.qualityindicators.ahrq.gov\/modules\/pqi_resources.aspx. Accessed August 26, 2018."},{"key":"pone.0222868.ref020","unstructured":"IMS Health. The Uniform System of Classification (USC) 2008. Available from: https:\/\/www.imshealth.com\/files\/web\/IMSH%20Institute\/USC_Classiification_Process_2011.pdf."},{"key":"pone.0222868.ref021","unstructured":"U.S. Food and Drug Administration. National Drug Code Directory. Available: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ndc\/. Accessed August 29, 2018."},{"key":"pone.0222868.ref022","unstructured":"Nau D. Proportion of days covered (PDC) as a preferred measure of medication adherence. Pharmacy Quality Alliance. Available from: http:\/\/www.pqaalliance.org\/images\/uploads\/files\/PQA%20PDC%20vs%20%20MPR.pdc. Accessed March 11, 2019."},{"key":"pone.0222868.ref023","unstructured":"National Quality Forum. National Voluntary Consensus Standards for Medication Management 2010. Available: http:\/\/www.qualityforum.org\/Publications\/2010\/05\/National_Voluntary_Consensus_Standards_for_Medication_Management.aspx. Accessed June 29, 2018."},{"key":"pone.0222868.ref024","unstructured":"Kuhle J. PQA Measures Used by CMS in the Star Ratings. Available: http:\/\/pqaalliance.org\/measures\/cms.asp. Accessed August 26, 2018."},{"issue":"7","key":"pone.0222868.ref025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007998","article-title":"Timing of Postdischarge Follow-Up and Medication Adherence Among Patients With Heart Failure","volume":"7","author":"LL Chang","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"pone.0222868.ref026","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"NK Choudhry","year":"2009","journal-title":"Am J Manag Care"},{"issue":"6","key":"pone.0222868.ref027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006056","article-title":"Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population-Based Cohort Study","volume":"6","author":"Q Yang","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"8","key":"pone.0222868.ref028","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes","volume":"68","author":"S Bansilal","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"pone.0222868.ref029","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/STROKEAHA.107.504688","article-title":"Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population","volume":"39","author":"J Tang","year":"2008","journal-title":"Stroke"},{"key":"pone.0222868.ref030","unstructured":"USDHHS HRSA, Bureau of Health Professions. Area Health Resources Files (AHRF). Available: http:\/\/ahrf.hrsa.gov\/. Accessed August 29, 2018."},{"key":"pone.0222868.ref031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2288-10-20","article-title":"Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer","volume":"10","author":"CA Bellera","year":"2010","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"pone.0222868.ref032","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ahj.2009.07.034","article-title":"Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF)","volume":"158","author":"AV Ambardekar","year":"2009","journal-title":"Am Heart J"},{"issue":"16","key":"pone.0222868.ref033","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMsa1513024","article-title":"Readmissions, Observation, and the Hospital Readmissions Reduction Program","volume":"374","author":"RB Zuckerman","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0222868.ref034","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/clc.22711","article-title":"Centers for Medicare and Medicaid Services' readmission reports inaccurately describe an institution's decompensated heart failure admissions","volume":"40","author":"ZL Cox","year":"2017","journal-title":"Clin Cardiol"},{"issue":"9","key":"pone.0222868.ref035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jchf.2017.04.008","article-title":"Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure","volume":"5","author":"B Ziaeian","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"2","key":"pone.0222868.ref036","doi-asserted-by":"crossref","first-page":"e002444","DOI":"10.1161\/CIRCHEARTFAILURE.115.002444","article-title":"Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry","volume":"9","author":"P Khazanie","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"9","key":"pone.0222868.ref037","first-page":"814","article-title":"The implications of therapeutic complexity on adherence to cardiovascular medications","volume":"171","author":"NK Choudhry","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"pone.0222868.ref038","first-page":"391","article-title":"Understanding reasons for nonadherence to medications in a medicare part d beneficiary sample","volume":"21","author":"AL Hincapie","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"issue":"2\u20133","key":"pone.0222868.ref039","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5273(00)00374-0","article-title":"Reasons for adherence with antihypertensive medication","volume":"76","author":"S Svensson","year":"2000","journal-title":"Int J Cardiol"},{"key":"pone.0222868.ref040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/PPA.S18481","article-title":"Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey","volume":"5","author":"KV Nair","year":"2011","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"pone.0222868.ref041","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.japh.2015.12.014","article-title":"Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients","volume":"56","author":"S Heldenbrand","year":"2016","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"7","key":"pone.0222868.ref042","first-page":"e53","article-title":"Impact of workplace health services on adherence to chronic medications","volume":"15","author":"BW Sherman","year":"2009","journal-title":"Am J Manag Care"},{"issue":"8","key":"pone.0222868.ref043","first-page":"670","article-title":"Impact of Employer-Sponsored Onsite Pharmacy and Condition Management Programs on Medication Adherence","volume":"21","author":"KM Aguilar","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"pone.0222868.ref044","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1331\/JAPhA.2012.11186","article-title":"Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs","volume":"52","author":"LA Shimp","year":"2012","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"6","key":"pone.0222868.ref045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pcad.2013.02.001","article-title":"Adherence to cardiovascular medications: lessons learned and future directions","volume":"55","author":"IM Kronish","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"pone.0222868.ref046","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.hfc.2014.04.003","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"10","author":"C Andersson","year":"2014","journal-title":"Heart Fail Clin"},{"issue":"10","key":"pone.0222868.ref047","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-146-10-200705150-00005","article-title":"Pharmacist intervention to improve medication adherence in heart failure: a randomized trial","volume":"146","author":"MD Murray","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"pone.0222868.ref048","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.amjcard.2008.11.058","article-title":"Causes and consequences of nonpersistence with heart failure medication","volume":"103","author":"M Mockler","year":"2009","journal-title":"Am J Cardiol"},{"issue":"8","key":"pone.0222868.ref049","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1592\/phco.26.8.1157","article-title":"Drug copayment and adherence in chronic heart failure: effect on cost and outcomes","volume":"26","author":"JA Cole","year":"2006","journal-title":"Pharmacotherapy"},{"key":"pone.0222868.ref050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.healthpol.2017.02.008","article-title":"Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure","volume":"121","author":"G Gourzoulidis","year":"2017","journal-title":"Health Policy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:04:53Z","timestamp":1588968293000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222868"}},"subtitle":[],"editor":[{"given":"Srikant","family":"Devaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222868","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]}}}